Cloning Concerns
By Richard Hayes,
Washington Post
| 11. 24. 2007
As the Nov. 21 front-page article "Advance May End Stem Cell Debate" implied, religious conservatives are not the only ones concerned about the use of human cloning for stem cell research. Many liberals, progressives and supporters of women's health and reproductive rights are uneasy for reasons of their own.
Cloning-based stem cell therapies have been projected to cost upward of $100,000 per treatment, raising questions of health equity and access.
Cloning for stem cell research opens the door to reproductive cloning and to high-tech eugenic and "designer baby" applications. And millions of women's eggs would be needed each year to supply the proposed cloning-based "personalized medicine" industry.
With this week's stem cell breakthroughs, the embryo wars may be behind us. Liberals are now in a position to take the lead in drawing attention to the social justice and human rights concerns that the new human genetic technologies raise.
RICHARD HAYES
Executive Director
Center for Genetics and Society
Oakland, Calif.
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...